Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04455009 · ClinicalTrials.gov registry record · NA
Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT04455009: Completed NA study, sponsored by University of Central Florida.
NCT04455009 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04455009, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this investigation was to examine the acute effects of consuming two different fitness drink formulas on the physiological response at rest and to exercise in healthy men and women.
Primary Outcome
Estimates from gas exchange analysis via indirect calorimetry
Interventions
- DIETARY_SUPPLEMENT Fitness Drink Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2018-11-28 |
| Phase | NA |
What the finished NCT04455009 record still lists
NCT04455009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Fitness Drink Formula is the first listed.
NCT04455009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04455009 about?
NCT04455009 is a clinical study titled "Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism". The purpose of this investigation was to examine the acute effects of consuming two different fitness drink formulas on the physiological response at rest and to exercise in healthy men and women.
What is the current status of trial NCT04455009?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-03-08. Estimated completion is 2018-11-28.
What interventions are being tested in trial NCT04455009?
The interventions under investigation include: Fitness Drink Formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04455009?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04455009's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI